Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 3 | $409,328 |
| Sells | 79 | $4,491,842 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 19:52 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remarks | 19 Nov 2024 | Sale | 1,775 | 9.6847 | 17,190 | D |
| 18 Nov 2024 19:04 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 14 Nov 2024 | Sale | 50,749 | 10.2945 | 522,436 | D |
| 18 Nov 2024 19:04 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 14 Nov 2024 | Sale | 18,377 | 10.2945 | 189,182 | D |
| 18 Nov 2024 19:04 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 15 Nov 2024 | Sale | 100 | 10.03 | 1,003 | D |
| 13 Nov 2024 18:45 | ARQT | Arcutis Biotherapeutics Inc | CURRAN TERRIE | Director | 11 Nov 2024 | Sale | 8,687 | 10.8482 | 94,238 | D |
| 05 Nov 2024 16:46 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remarks | 04 Nov 2024 | Sale | 5,015 | 8.6842 | 43,551 | D |
| 05 Nov 2024 16:46 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 04 Nov 2024 | Sale | 13,871 | 8.6842 | 120,459 | D |
| 05 Nov 2024 16:46 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 01 Nov 2024 | Sale | 10,000 | 8.6541 | 86,541 | D |
| 05 Nov 2024 16:45 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 04 Nov 2024 | Sale | 15,441 | 8.6842 | 134,093 | D |
| 03 Oct 2024 16:55 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 01 Oct 2024 | Sale | 10,000 | 9.2616 | 92,616 | D |
| 03 Oct 2024 16:55 | ARQT | Arcutis Biotherapeutics Inc | EDWARDS LARRY TODD | SVP Chief Commercial Officer | 02 Oct 2024 | Sale | 3,725 | 10.0122 | 37,295 | D |
| 25 Sep 2024 21:42 | ARQT | Arcutis Biotherapeutics Inc | TOPPER DAVID JOSEPH | Chief Financial Officer | 24 Sep 2024 | Sale | 11,626 | 9.4843 | 110,264 | D |
| 05 Sep 2024 17:56 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 03 Sep 2024 | Sale | 10,000 | 10.7695 | 107,695 | D |
| 21 Aug 2024 16:39 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 19 Aug 2024 | Sale | 1,728 | 8.286 | 14,318 | D |
| 05 Aug 2024 16:37 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remarks | 02 Aug 2024 | Sale | 5,220 | 9.0161 | 47,064 | D |
| 05 Aug 2024 16:37 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 02 Aug 2024 | Sale | 13,206 | 9.0191 | 119,106 | D |
| 05 Aug 2024 16:37 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 02 Aug 2024 | Sale | 14,487 | 9.0183 | 130,648 | D |
| 05 Aug 2024 16:37 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 01 Aug 2024 | Sale | 3,386 | 9.8696 | 33,418 | D |
| 05 Aug 2024 16:37 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 01 Aug 2024 | Sale | 6,614 | 9.8696 | 65,278 | D |
| 02 Jul 2024 19:13 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 01 Jul 2024 | Sale | 10,000 | 9.3141 | 93,141 | D |
| 06 Jun 2024 16:15 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 04 Jun 2024 | Sale | 3,542 | 8 | 28,336 | D |
| 06 Jun 2024 16:15 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 04 Jun 2024 | Sale | 6,458 | 8.0142 | 51,756 | D |
| 31 May 2024 16:50 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 30 May 2024 | Sale | 23,000 | 8.753 | 201,319 | D |
| 31 May 2024 16:50 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 29 May 2024 | Sale | 49,952 | 8.7161 | 435,387 | D |
| 29 May 2024 19:38 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remark | 28 May 2024 | Sale | 1,775 | 9.0074 | 15,988 | D |
| 20 May 2024 17:12 | ARQT | Arcutis Biotherapeutics Inc | EDWARDS LARRY TODD | SVP Chief Commercial Officer | 17 May 2024 | Sale | 7,640 | 8.9767 | 68,582 | D |
| 03 May 2024 16:29 | ARQT | Arcutis Biotherapeutics Inc | MOORE MATTHEW RICHARD | SVP and Chief Business Officer | 02 May 2024 | Sale | 4,681 | 8.7378 | 40,902 | D |
| 03 May 2024 16:22 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 02 May 2024 | Sale | 13,783 | 8.7378 | 120,433 | D |
| 03 May 2024 16:22 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remark | 02 May 2024 | Sale | 5,016 | 8.7378 | 43,829 | D |
| 03 May 2024 16:22 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 02 May 2024 | Sale | 9,555 | 8.7378 | 83,490 | D |
| 06 Mar 2024 17:14 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remark | 04 Mar 2024 | Sale | 3,760 | 11.1212 | 41,816 | D |
| 06 Mar 2024 17:12 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 04 Mar 2024 | Sale | 4,782 | 11.1212 | 53,182 | D |
| 06 Mar 2024 17:09 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 04 Mar 2024 | Sale | 14,903 | 11.1212 | 165,739 | D |
| 06 Mar 2024 17:08 | ARQT | Arcutis Biotherapeutics Inc | MOORE MATTHEW RICHARD | SVP and Chief Business Officer | 04 Mar 2024 | Sale | 3,468 | 11.1212 | 38,568 | D |
| 06 Mar 2024 16:28 | ARQT | Arcutis Biotherapeutics Inc | HERON PATRICK J | Director | 04 Mar 2024 | Purchase | 21,052 | 9.5 | 199,994 | I |
| 01 Mar 2024 16:11 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 28 Feb 2024 | Sale | 2,465 | 10.6 | 26,129 | D |
| 03 Jan 2024 17:30 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 02 Jan 2024 | Sale | 1,325 | 3.5408 | 4,692 | D |
| 01 Dec 2023 20:51 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 31 May 2023 | Purchase | 1,463 | 6.38 | 9,334 | D |
| 21 Nov 2023 17:47 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remark | 21 Nov 2023 | Sale | 1,850 | 1.979 | 3,661 | D |
| 26 Oct 2023 16:09 | ARQT | Arcutis Biotherapeutics Inc | FRAZIER LIFE SCIENCES VIII, L.P. | 10% | 24 Oct 2023 | Purchase | 80,000 | 2.5 | 200,000 | D |
| 22 Aug 2023 12:24 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 21 Aug 2023 | Sale | 1,305 | 7.04 | 9,187 | D |
| 22 Aug 2023 12:24 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 21 Aug 2023 | Sale | 300 | 7.05 | 2,115 | D |
| 02 Jun 2023 20:31 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remark | 31 May 2023 | Sale | 1,830 | 7.8023 | 14,278 | D |
| 18 Apr 2023 19:00 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 17 Apr 2023 | Sale | 8,500 | 13.968 | 118,728 | D |
| 10 Apr 2023 16:13 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 06 Apr 2023 | Sale | 8,500 | 12.01 | 102,085 | D |
| 08 Mar 2023 16:29 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 06 Mar 2023 | Sale | 2,435 | 15.2638 | 37,167 | D |
| 08 Mar 2023 16:29 | ARQT | Arcutis Biotherapeutics Inc | BURROWS SCOTT L | Chief Financial Officer | 06 Mar 2023 | Sale | 291 | 15.2634 | 4,442 | D |
| 08 Mar 2023 16:28 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 06 Mar 2023 | Sale | 851 | 15.2634 | 12,989 | D |
| 08 Mar 2023 16:26 | ARQT | Arcutis Biotherapeutics Inc | TURNEY PATRICIA A. | SVP, Operations | 06 Mar 2023 | Sale | 831 | 15.2635 | 12,684 | D |
| 08 Mar 2023 16:26 | ARQT | Arcutis Biotherapeutics Inc | OSBORNE DAVID W | Chief Technical Officer | 06 Mar 2023 | Sale | 690 | 15.2634 | 10,532 | D |
| 08 Mar 2023 16:25 | ARQT | Arcutis Biotherapeutics Inc | LOCK KENNETH A. | Chief Commercial Officer | 06 Mar 2023 | Sale | 831 | 15.2636 | 12,684 | D |
| 06 Mar 2023 18:54 | ARQT | Arcutis Biotherapeutics Inc | MOORE MATTHEW RICHARD | See Remarks | 02 Mar 2023 | Sale | 21 | 16.52 | 347 | D |
| 06 Mar 2023 18:54 | ARQT | Arcutis Biotherapeutics Inc | MOORE MATTHEW RICHARD | See Remarks | 02 Mar 2023 | Sale | 1,589 | 15.8177 | 25,134 | D |
| 06 Mar 2023 18:52 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remarks | 02 Mar 2023 | Sale | 18 | 16.52 | 297 | D |
| 06 Mar 2023 18:52 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remarks | 02 Mar 2023 | Sale | 1,416 | 15.8181 | 22,398 | D |
| 06 Mar 2023 18:51 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 02 Mar 2023 | Sale | 23 | 16.52 | 380 | D |
| 06 Mar 2023 18:51 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 02 Mar 2023 | Sale | 1,728 | 15.8178 | 27,333 | D |
| 02 Mar 2023 19:07 | ARQT | Arcutis Biotherapeutics Inc | TURNEY PATRICIA A. | SVP, Operations | 02 Mar 2023 | Sale | 18 | 16.52 | 297 | D |
| 02 Mar 2023 19:07 | ARQT | Arcutis Biotherapeutics Inc | TURNEY PATRICIA A. | SVP, Operations | 02 Mar 2023 | Sale | 1,414 | 15.8183 | 22,367 | D |
| 02 Mar 2023 19:07 | ARQT | Arcutis Biotherapeutics Inc | TURNEY PATRICIA A. | SVP, Operations | 28 Feb 2023 | Sale | 936 | 16.1663 | 15,132 | D |
| 02 Mar 2023 19:06 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 02 Mar 2023 | Sale | 69 | 16.52 | 1,140 | D |
| 02 Mar 2023 19:06 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 02 Mar 2023 | Sale | 5,403 | 15.8182 | 85,466 | D |
| 02 Mar 2023 19:06 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 28 Feb 2023 | Sale | 2,343 | 16.1663 | 37,878 | D |
| 02 Mar 2023 19:05 | ARQT | Arcutis Biotherapeutics Inc | BURROWS SCOTT L | Chief Financial Officer | 02 Mar 2023 | Sale | 18 | 16.52 | 297 | D |
| 02 Mar 2023 19:05 | ARQT | Arcutis Biotherapeutics Inc | BURROWS SCOTT L | Chief Financial Officer | 02 Mar 2023 | Sale | 1,416 | 15.8183 | 22,399 | D |
| 02 Mar 2023 19:05 | ARQT | Arcutis Biotherapeutics Inc | BURROWS SCOTT L | Chief Financial Officer | 28 Feb 2023 | Sale | 416 | 16.1663 | 6,725 | D |
| 02 Mar 2023 19:04 | ARQT | Arcutis Biotherapeutics Inc | LOCK KENNETH A. | Chief Commercial Officer | 02 Mar 2023 | Sale | 18 | 16.52 | 297 | D |
| 02 Mar 2023 19:04 | ARQT | Arcutis Biotherapeutics Inc | LOCK KENNETH A. | Chief Commercial Officer | 02 Mar 2023 | Sale | 1,414 | 15.8182 | 22,367 | D |
| 02 Mar 2023 19:04 | ARQT | Arcutis Biotherapeutics Inc | LOCK KENNETH A. | Chief Commercial Officer | 28 Feb 2023 | Sale | 936 | 16.1663 | 15,132 | D |
| 02 Mar 2023 19:03 | ARQT | Arcutis Biotherapeutics Inc | OSBORNE DAVID W | Chief Technical Officer | 02 Mar 2023 | Sale | 15 | 16.52 | 248 | D |
| 02 Mar 2023 19:03 | ARQT | Arcutis Biotherapeutics Inc | OSBORNE DAVID W | Chief Technical Officer | 02 Mar 2023 | Sale | 1,198 | 15.8185 | 18,951 | D |
| 02 Mar 2023 19:03 | ARQT | Arcutis Biotherapeutics Inc | OSBORNE DAVID W | Chief Technical Officer | 28 Feb 2023 | Sale | 792 | 16.1663 | 12,804 | D |
| 21 Feb 2023 07:20 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 15 Feb 2023 | Sale | 8,500 | 16.9826 | 144,352 | D |
| 15 Feb 2023 19:09 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 14 Feb 2023 | Sale | 100 | 17.03 | 1,703 | D |
| 15 Feb 2023 19:09 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 14 Feb 2023 | Sale | 417 | 17.02 | 7,097 | D |
| 15 Feb 2023 19:09 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 13 Feb 2023 | Sale | 42 | 17.01 | 714 | D |
| 15 Feb 2023 19:09 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 13 Feb 2023 | Sale | 441 | 17 | 7,497 | D |
| 03 Feb 2023 16:26 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 01 Feb 2023 | Sale | 382 | 17 | 6,494 | D |
| 03 Feb 2023 16:26 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 01 Feb 2023 | Sale | 618 | 17.0044 | 10,509 | D |
| 18 Jan 2023 20:18 | ARQT | Arcutis Biotherapeutics Inc | WELGUS HOWARD G. | Director | 17 Jan 2023 | Sale | 8,500 | 13.7241 | 116,655 | D |
| 04 Jan 2023 17:15 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 03 Jan 2023 | Sale | 1,475 | 15.0075 | 22,136 | D |
| 09 Dec 2022 16:47 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 07 Dec 2022 | Sale | 1,000 | 17.06 | 17,060 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)